22.09.2017 - Israeli generics giant Teva has completed its exit from the women’s health sector. On Sept. 18 it unloaded its contraception, fertility, menopause and osteoporosis products to CVC...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)